“Clinical trial of 20% Mat lippia (bucan) topical ointment for cutaneous leishmaniasis; a preliminary trial” (2016) Journal of Pakistan Association of Dermatologists, 15(2), pp. 108–112. doi:10.66344/jpad.15.2.2005.627.